4
Changes in Ownership
Janux Therapeutics, Inc. Filed Acc 0001415889-24-019903
Director acquired 7,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Hernday Natasha · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-07-19 | Grant or award : show line 1 in the form | +5,000 | 5,000 | D |
| 2024-07-19 | Grant or award : show line 2 in the form | +2,500 | 7,500 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-07-19 | Grant or award : show line 3 in the form Stock Option (Right to Buy) | +16,700 | 16,700 | D |
| 2024-07-19 | Grant or award : show line 4 in the form Stock Option (Right to Buy) | +8,350 | 8,350 | D |
Loading xslF345X05/form4-07232024_120716.xml…